| 名稱 | E.G7-OVA(OVA/EL4) |
| 型號(hào) | CBPG0124 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | E.G7-OVA(OVA/EL4) |
產(chǎn)品搜索
相關(guān)文章
- 甲基丙二酸血癥（MMA）標(biāo)準(zhǔn)品上新
- 潛力十足的T細(xì)胞療法，我們用得起嗎？
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
- GABA細(xì)胞篩選模型
- ATCC細(xì)胞株所用培養(yǎng)基有何要求？
- 腫瘤細(xì)胞的凋亡與壞死有何區(qū)別？
- ATCC細(xì)胞如何培養(yǎng)？
- 慢病毒整合位點(diǎn)標(biāo)準(zhǔn)品的應(yīng)用現(xiàn)狀與創(chuàng)新
- 科佰Bcr-AbL激酶細(xì)胞模型助力客戶發(fā)表高分文獻(xiàn)（IF 15.1）
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBPG0124E.G7-OVA(OVA/EL4)
- 詳細(xì)內(nèi)容
E.G7-OVA(OVA/EL4) E.G7-OVA(OVA/EL4) E.G7-OVA(OVA/EL4)
| I. Background | |
| E.G7-OVA was derived in 1988 from the C57BL/6 (H-2 b) mouse lymphoma cell line EL4 (ATCC TIB-39). The EL4 cells were transfected by electroporation with the plasmid pAc-neo-OVA which carries a complete copy of chicken ovalbumin (OVA) mRNA and the neomycin (G418) resistance gene. | |
| II. Introduction | |
| Expressed gene: | OVA |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+0.05mM 2-mercaptoethanol+0.4 mg/ml G418 |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| III. Description of Host Cell Line | |
| Organism: | Mus musculus, mouse |
| Tissue: | T lymphocyte |
| Morphology: | Epithelial |
| Growth Properties: | suspension |
會(huì)員_a.png)